“…In this sense, biosensor technology can represent a very attractive alternative or complementary approach to detect this biomarker because of their inherent advantages such as simplicity, low cost and possible miniaturization. In fact, recently, different types of biosensors have been developed for HER2 detection [ 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ]. Considering the biorecognition element used in biosensors, antibodies are the most popular choice [ 15 ], but aptamers have emerged as an interesting alternative due to the great advantages they have over antibodies, such as higher specificity, greater design flexibility, and more stability and availability [ 23 ].…”